Advertisement Rosetta Genomics And SRL Sign Distribution Agreement - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Rosetta Genomics And SRL Sign Distribution Agreement

Rosetta Genomics, Ltd. (Rosetta Genomics), a developer of microRNA-based molecular diagnostics, and Super Religare Laboratories Limited (SRL), India's diagnostics network, have signed an distribution agreement for Rosetta Genomics' three currently-available diagnostic tests. The distribution agreement provides, SRL to market Rosetta Genomics' miRview tests in India, Saudi Arabia, Qatar, and the UAE.

Samples will be sent from SRL’s territories to Rosetta Genomics’ Philadelphia-based CLIA-certified laboratory for analysis. The terms of the deal were not disclosed.

SRL will distribute miRview mets, miRview squamous and miRview meso.